New AI-powered TIMSquant™ software for CCS-enabled, label-free quantification scalable to thousands of samples
Early midia-PASEF® access for immunopeptidomics and PTMs on ultra-sensitive.
Bruker announces new results in deep, unbiased plasma proteomics, PaSER 1.1 software and new cross-linking consumables at US HUPO 2021
At the virtual 17
th US HUPO Conference (US HUPO 2021), Bruker Corporation (Nasdaq: BRKR) today announces progress with several collaborations in deep, unbiased plasma proteomics, leveraging the speed, sensitivity and dynamic range of 4D proteomics on timsTOF Pro systems.
Figure 1. Large-scale peptide CCS measurement with TIMS and PASEF. www.nature.com/articles/s41467-021-21352-8
New results from a key collaborator, Professor Kirk Hansen of the University of Colorado Anschutz Medical Center, will be presented at Bruker’s virtual seminar at US HUPO on Tuesday, March 9